PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
billion
View All ->
Americold Successfully Closes $1.3 Billion North American Cold Storage Joint Venture with EQT
ATLANTA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced the closing of its previously announced North American cold storage joint venture with EQT's Active Core Infrastructure fund (“EQT”). The joint venture owns a diverse portfolio of 12 temperature-controlled ware
A Single AI Data Center Lease Just Locked In Up to $3.2 Billion, and a Tiny Public Company Is About to Inherit It
News Provided by Equity Insider on behalf of Healthy Choice Wellness Corp. NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The scarcest commodity in artificial intelligence right now is not talent or even chips. It is power-ready real estate: sites with energized electrical capacity, cooling, and interconnection rights that can host the enormous compute clusters AI demands, available on the timeline the market needs them. That scarcity is what turns a single, well-lo
newsA Single AI Data Center Lease Just Locked In Up to $3.2 Billion, and a Tiny Public Company Is About to Inherit It
News Provided by Equity Insider on behalf of Healthy Choice Wellness Corp. NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The scarcest commodity in artificial intelligence right now is not talent or even chips. It is power-ready real estate: sites with energized electrical capacity, cooling, and interconnection rights that can host the enormous compute clusters AI demands, available on the timeline the market needs them. That scarcity is what turns a single, well-lo
Business Digest
newsWhole Exome Sequencing Market to Hit USD 10.24 Billion by 2035 as Precision Medicine Adoption Accelerates – SNS Insider
newsAI Integration Reshapes the Plastics in Electronics Components Market as Hyperscale Infrastructure Investment Surpasses $650 Billion
newsAI Integration Reshapes the Wireless Electric Vehicle Charging Landscape, Unlocking Efficiency Gains and Billions in Infrastructure Investment
market
View All ->MARKET-LEADING CAPITAL MARKETS AND M&A PARTNERS TO JOIN LATHAM & WATKINS IN HONG KONG
Highly regarded partners Grace Huang and Edward Freeman will further strengthen Latham s preeminent platform in Asia, bringing deep expertise in sophisticated cross-border transactions. HONG KONG , Sept. 1, 2026 -- Latham & Watkins LLP is pleased to announce that Grace Huang and Edward Freeman will join the firm as partners in the Hong Kong office. Huang will join the Capital Markets Practice, while Freeman will join the M&A and Private Equity Practice. Widely recognized as among a small group of elite practitioners in their respective fields, the arrival of Huang and Freeman marks a significant milestone in the expansion of the firm s preeminent transactional platform in Asia.
A Single AI Data Center Lease Just Locked In Up to $3.2 Billion, and a Tiny Public Company Is About to Inherit It
News Provided by Equity Insider on behalf of Healthy Choice Wellness Corp. NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The scarcest commodity in artificial intelligence right now is not talent or even chips. It is power-ready real estate: sites with energized electrical capacity, cooling, and interconnection rights that can host the enormous compute clusters AI demands, available on the timeline the market needs them. That scarcity is what turns a single, well-lo
newsA Single AI Data Center Lease Just Locked In Up to $3.2 Billion, and a Tiny Public Company Is About to Inherit It
News Provided by Equity Insider on behalf of Healthy Choice Wellness Corp. NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The scarcest commodity in artificial intelligence right now is not talent or even chips. It is power-ready real estate: sites with energized electrical capacity, cooling, and interconnection rights that can host the enormous compute clusters AI demands, available on the timeline the market needs them. That scarcity is what turns a single, well-lo
Business Digest
newsNontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
newsWireless Electric Vehicle Chargers Market to Reach $738.3 Million by 2030, Driven by Accelerating BEV Adoption and OEM Integration
newsWhole Exome Sequencing Market to Hit USD 10.24 Billion by 2035 as Precision Medicine Adoption Accelerates – SNS Insider
announces
View All ->PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, announced today the pricing of an underwritten public offering consisting of (i) 22,055,000 shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase an aggregate of up to 19,900,000 shares of its common stock,
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments. Q2 2026 Financial Highl
newsInflection Point Acquisition Corp. VIII Announces Closing of $287.5 Million Initial Public Offering
Miami Beach, FL, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. VIII (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the full exercise by the underwriters of their over
Business Digest
newsPyxis Tankers Announces Financial Results for the Three & Six Months Ended June 30, 2026
newsOSL Group Announces 2026 Interim Results: Payment Business Drives Core Revenue, Forging Leading Global Stablecoin Payment Infrastructure
newsInternational Petroleum Corporation Announces Results of Normal Course Issuer Bid and Updated Share Capital
results
View All ->
Argo Reports Q2 2026 Results: 680% Revenue Growth
Revenue increases 680% to $2.9 million; operating loss declines 79% year-over-year TORONTO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Argo Corporation (TSXV: ARGH) (OTCQX: ARGHF) (“ Argo ” or the “ Company ”), a leader in next-generation public transit solutions, announced its financial results for the three and six months ended June 30, 2026 (“ Q2 2026 ”). All figures are in Canadian dollars unless otherwise noted. Q2 2026 Highlights Revenue: Q2 revenue increased 680% to $2.9 million, from $0.4 million
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments. Q2 2026 Financial Highl
newsYD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced its financial results for the six months ended June 30, 2026. Management Commentary “ The first half of 2026 marks a historic turning point for YD Bio, highlighted by our transition to bottom-line profitability and a remarkable 315% surge in top-line revenue,
form
View All ->
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 million Company accelerated payment of $42.6 million upfront, bringing total payments made to date to $50 million, a full return of NQ Project Phoebus, L.P.’s invested capital, with up to $15 million of additional royalty-based payments to follow Remaining payments, capped at $15 million, to be paid from 50% of the revenue received from Astellas in the Astellas territories excluding Japa
AI Disruption in Footwear Recycling Accelerates as Investor Capital and Brand Mandates Force Industry Transformation
“AI-enabled dismantling systems can now process up to 120 shoes per hour, while advanced recycling technologies are cutting CO₂ emissions by 50% and helping brands scale circular footwear programs beyond labor-intensive mechanical recycling.” Boston, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The footwear recycling industry stands at an inflection point as artificial intelligence emerges as the critical enabler for scaling what has historically been a fragmented, labor-intensive, and economically unviabl
newsNew genomics collaboration to enable First Nations sovereignty over salmon data
Pit tagging and sampling juvenile Chinook Pit tagging and sampling juvenile Chinook salmon to test for environmental stressors and track survival over their lifespan. Photo by Mack Bartlett (Ha'oom Fisheries Society and Juanes Lab, University of Victoria). VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- A new multi-year, multi-partner collaboration aims to empower First Nations communities in British Columbia with salmon genetic analysis tools, technology, infrastructure and skill